Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, settembre 23
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
CareDx Inc
CDNA
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$56.49
2.16
3.98%
In chiusura: Sep 22, 5:00 PM EST
$55.79
-0.70
-1.25%
Post-mercato: 7:55 PM EST
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
CareDx Financials
CareDx (CDNA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
CareDx Q2 Adj. EPS $0.37 Beats $0.23 Estimate, Sales $131.948M Beat $114.044M Estimate
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.37 per share which beat the analyst consensus estimate of $0.23 by 60.87 percent. This is a 270 percent increase over earnings of $0.10 per share from the same
Benzinga Newsdesk
PRO
CareDx Raises FY2026 Sales Guidance from $447.000M-$465.000M to $490.000M-$500.000M vs $455.924M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $447.000 million-$465.000 million to $490.000 million-$500.000 million vs $455.924 million estimate.
Benzinga Newsdesk
PRO
CareDx Raises FY2026 Sales Guidance from $420.000M-$444.000M to $447.000M-$465.000M vs $436.665M Est
CareDx (NASDAQ:CDNA) raises FY2026 sales outlook from $420.000 million-$444.000 million to $447.000 million-$465.000 million vs $436.665 million estimate.
Benzinga Newsdesk
PRO
CareDx Q1 Adj. EPS $0.34 Beats $0.13 Estimate, Sales $117.700M Beat $104.034M Estimate
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.13 by 161.54 percent. This is a 277.78 percent increase over earnings of $0.09 per share from the same
Benzinga Newsdesk
Earnings Scheduled For April 28, 2026
Benzinga Insights
CareDx Sharpens Focus On Core Testing Services
CareDx Inc. (CDNA) sells Lab Products business to EuroBio Scientific for $170 million in cash, focusing on higher-growth precision testing and digital solutions.
Vandana Singh
Privacy Manager